Vitamin K2: the supplement often paired with vitamin D

Vitamin K2 (menaquinones) is one of two main forms of vitamin K, the other being K1 (phylloquinone) found in leafy greens. K2 has accumulated supplement-shop confidence as the "essential pairing" with vitamin D, particularly in the bone-and-arteries narrative around calcium handling.

The biology is genuinely interesting. The clinical evidence in healthy adults is smaller than the marketing suggests.

What vitamin K2 does#

Both K1 and K2 are cofactors for gamma-glutamyl carboxylation, a post-translational modification of proteins that allows them to bind calcium. K-dependent proteins include:

• Osteocalcin in bone: undercarboxylated osteocalcin is associated with worse bone outcomes
• Matrix Gla protein (MGP) in arteries: under-carboxylated MGP has been associated with arterial calcification in observational studies
• Several clotting factors — the reason warfarin (a vitamin K antagonist) is used as an anticoagulant

The two main subtypes in supplements are MK-4 (short half-life, more common in animal foods) and MK-7 (long half-life, more common in fermented foods like natto).

The evidence in healthy adults#

Bone health. Trials of K2 (particularly high-dose MK-4 in Japanese trials, 45 mg/day) have shown reduced fracture risk in osteoporotic populations. Lower-dose MK-7 supplementation in healthy older adults has shown effects on bone-turnover markers; effects on fracture incidence are smaller.

Cardiovascular outcomes. The most-cited observational study is the Rotterdam Study (Geleijnse et al. 2004): higher dietary K2 intake associated with lower cardiovascular mortality and aortic calcification. Replication has been mixed. The few interventional trials have used surrogate markers (arterial stiffness, MGP carboxylation) with modest effects.

Combination with vitamin D. The popular claim is that taking vitamin D without K2 risks misdirected calcium deposition in arteries instead of bones. The mechanistic story is plausible but the human evidence is sparse; large vitamin D trials (VITAL) have not shown excess cardiovascular calcification, and no large RCT has demonstrated that adding K2 to vitamin D supplementation reduces cardiovascular events.

The dietary baseline#

K1 is abundant in leafy green vegetables; K2 comes from:

• Natto (Japanese fermented soybeans): by far the highest K2 source, with very high MK-7 content
• Aged cheeses (especially Dutch Gouda, Edam)
• Egg yolks
• Liver
• Some fermented foods

Western diets are typically low in K2 but not deficient by current reference intakes. Vegetarians and vegans not eating fermented soy can be low.

Doses in trials#

• MK-7 (long half-life form) is usually used at 90–180 mcg/day in healthy-adult trials
• MK-4 (short half-life form) is used at much higher doses (5–45 mg/day in Japanese bone trials)

The two are not directly equivalent. MK-7 is the more common consumer supplement form because of dosing convenience and reasonable bioavailability.

Side effects and interactions#

K vitamins are generally well-tolerated. The major interaction to know about:

• Warfarin: K2 supplementation reduces warfarin's effect. Anyone on warfarin should not supplement K2 without their anticoagulation clinic's input.
• DOACs (direct oral anticoagulants like apixaban) do not have the same interaction.

Otherwise, supplemental K2 has a reassuring safety profile in trial data.

The honest read#

Vitamin K2 is real biology with a clear mechanistic story and an observational signal in cardiovascular and bone outcomes. The interventional evidence in healthy adults is C-grade: small trials, surrogate endpoints, modest effects.

The "must take K2 with D" advice is more confident than the evidence supports. A modest K2 supplement (e.g. 90 mcg MK-7) in someone already taking vitamin D is low-cost, low-risk, plausibly useful, but not demonstrably essential for healthy non-anticoagulated adults.

A reasonable position for most adults: get K2 from food where you can (cheese, eggs, occasionally natto if you'll eat it), supplement modestly if your diet is low in those, don't expect dramatic effects, and don't take it without clinical input if you're on warfarin.

The supplement-shop marketing that frames K2 as essential is overconfident. The biology that makes it interesting remains interesting.